{"name":"Treadwell Therapeutics, Inc","slug":"treadwell-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPTDcwc0YzQ0o1SDBocXhzbUFKMDdKQktrRmQyUXJ3d3RGV2Z4VURBbW02Z2ZhNlQ1dzRsXy1vTkJrWHZYMHBxWnljS21pVWdUQ0paT2dPQ19vQThKN1dZQnJLQXFRYlQ5OEhCalJKbWFyVkdLWmh2N0p3YUhhOUhZVHhBUHMwaFlJcWhHcnBGbDdHUmUtQWtrblEtRFM?oc=5","date":"2026-03-06","type":"trial","source":"openPR.com","summary":"TCR Therapy Clinical Trial Pipeline Accelerates as 50+ Pharma - openPR.com","headline":"TCR Therapy Clinical Trial Pipeline Accelerates as 50+ Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE8wTFljeERQcGxZcGJCQmFCNTBFUHQtUGFidU5YaS1uNDQtOWFQYWlFYVdyOWU3amx6ZzZPRkZRTkpFN2hJYl9LZllzaWxrS2lOUlRNV2VOYThyQmN5?oc=5","date":"2025-10-20","type":"pipeline","source":"EurekAlert!","summary":"Targeted immunotherapy combination offers hope to older adults with leukemia - EurekAlert!","headline":"Targeted immunotherapy combination offers hope to older adults with leukemia - EurekAlert!","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE0zTnB1NE14dGxoNzBXTHc2MnQ2bEVGLWVnZE9WckM4U1o2ZWp3b1pkdkNHOVAySzhBcDFXRGVEVEtmZk1UdGlpZEZVYzdFYUhMcmFKUm5XNHI3X1dDeHhN?oc=5","date":"2025-04-03","type":"trial","source":"nature.com","summary":"Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial | Blood Cancer Journal - nature.com","headline":"Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE5UNG0xRW9hRXRjWmFPRU0xQ0RLS1FsUFlnQnlUQzdhYVJidHZfSTY2dEVFMEdncVdocUUxVDNBVmJoS1g2bW9TMzlpc3RZTUkzT2xvb0FQc0JKamtuWUpXaG5CYllRdlhFRUJ6R3ZUWUVsZmRoVFJZQTZaZW8?oc=5","date":"2025-01-02","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Layoff Tracker 2024: Vincerx reduces workforce; Novartis lays off 330 staffers - Fierce Biotech","headline":"Fierce Biotech Layoff Tracker 2024: Vincerx reduces workforce; Novartis lays off 330 staffers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAJBVV95cUxNZXhndFV0WXBjTWJhMGpCeGJtckh3VWNCenI1MU1vVHY2U09LaGRqZUs2aDh4S29qajQ4bGZ6SXJMRXB0RU1LRUYtclhMc19TWXhHZ0ROOGVwbFBCLV9WWGFrWHBFSEdUTVFFVHhseUpMdE1UTmtKQTktMDNJWTRRd3M3cEc2d1lJUU1wMGMzdWFGS1VvUDloeXZfdUl6enpLMk1lLV9KS2N5bWo1cklZLVZYYW5mOTdZVk9fUUx5YVJKbHNQLW4zRjRkSTJlVmpaLVpCQm9vYkIzYjdBamJHb1c5M1NjeVlXT1RYT0E2ZHJCNGV1Y3R6YmJRaEtyY1kxOHJHc0ctLXRNbThrNWdLcDNvdnRmVThhVTFFZmhvem1ZQ0wzVzNuOFl0dE5mdG5TSkdGMA?oc=5","date":"2024-02-20","type":"regulatory","source":"businesswire.com","summary":"Treadwell Announces Ocifisertib, a First-in-Class PLK4 Inhibitor, has Received Orphan Designation from U.S. FDA for the Treatment of Acute Myeloid Leukemia - businesswire.com","headline":"Treadwell Announces Ocifisertib, a First-in-Class PLK4 Inhibitor, has Received Orphan Designation from U.S. FDA for the ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxQODM1VmxmWTdkcVFqdE5MYThVMVJkU3B0NFNTX3dnajVKcDM4REVKYmY3RHV5M1k4bXpLWHMwbnhXWmJHWWFYOUM1czFyTGlsWGhuR3MwN1dxd3JjdTBhdGxNckRnMzVDYjcxaXhtLWJiSXF5Tm41aWI4T3RXN3JXZWxzbFJVSzVIU1pONnV2QnhOMEp5OEVoYjJuWE5mZWROajMwWFA0WEZmZzdCeUE1a3hnTlFGYTQyTERvcDB2YTVtLUZVdkxwdG5Sdw?oc=5","date":"2024-02-13","type":"pipeline","source":"businesswire.com","summary":"Treadwell Announces the Formation and Members of Scientific Advisory Board - businesswire.com","headline":"Treadwell Announces the Formation and Members of Scientific Advisory Board","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAJBVV95cUxPMm1JUWdKNnB2UHByVzcwT2cwMWhNcXhpVl9PMTZ0Mk5pNXlTZVNEN0ZDT3dMLWdJUUlCYnBRTEoxdGJXZjFwYkdTRGNyczZqVjZHbUx1V0JISFFBc0h4QlpEUEZvemtFeG5nV3NidFh4dXAtbEYybXhOeU5aRW9qZDZQVExqZXhBcmdyaEJWbU5YTFo0V25EQ2V1MmNfb1dCWUJjejJPYTFWak5XdllvcFRZS1Z5WXdXd3Bzd3kxdFgtX0REYjJtQl9BalJ5bC15cXp2QXNrZnFIVjhjR2dtc2dwNElYQnZJUlg5clU1SU1xczNaY1ZXdXFrZ3BLLTdaU1c4ZlBsVjdXYU5ETXpsYWJKeFdEU0M5bkp4Rw?oc=5","date":"2022-08-04","type":"pipeline","source":"European Medical Journal","summary":"Management of Severe, Steroid-Resistant and Steroid-Refractory Hepatotoxicity in Patients Treated with Checkpoint Inhibitor Immunotherapy - European Medical Journal","headline":"Management of Severe, Steroid-Resistant and Steroid-Refractory Hepatotoxicity in Patients Treated with Checkpoint Inhibi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAJBVV95cUxQR0xEQ3d3T1pNNzBDbDVTcjZpVEZVUi0wYlZGdlUzWXhDT3lqNHlwb280R3pBNlpGQmczY093TE1aZ0ZaOEMxODJkZFpJb3RIVXBfNlVFNmZYZjhMcGNkMGVqMjlDQXlPODJCS2FTYm9DTG1kUnFKdlRkSlIzRjlFdjdkTDBlMUF2OHhZajhpRnEzUWhsU2czeU5YRFAyQ2J2YkNVV0ZxTmhjTzJueXVuRTNiNlh6NmQzUmY3dDlJYWRuQ2VnVjBLeTZvUmp5c0RLNlR2M0ZOMEh3QUI4VXk3ZXljM3NrRk9VNW5jYzdkVldBVmQ1SUlHQl9zLXhLNzdWZnJDZWkxNURpNVVLODNrOEFGb0xHaGdVYVhWVUZsRVBXSkIz?oc=5","date":"2021-10-15","type":"pipeline","source":"businesswire.com","summary":"Treadwell Therapeutics Announces Acquisition of TCRyption Inc., a Novel TCR-Based T Cell Therapy Company and TIO Bioventures Portfolio Company - businesswire.com","headline":"Treadwell Therapeutics Announces Acquisition of TCRyption Inc., a Novel TCR-Based T Cell Therapy Company and TIO Biovent","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}